REMEVi review
REMEVi is the first bilingual (English and Spanish) GLP-1 telehealth clinic — care delivered by clinicians trained in both languages, never auto-translated.
Pricing last checked on REMEVi's own site .
- Semaglutide
- $219/mo
- Tirzepatide
- $319/mo
- Coverage
- All 50 states
- Brand-name
- Compounded only
The scorecard
REMEVi scored on our six published factors. See the methodology.
What we like
- A genuinely flat rate: 'the same price at every dose', stated as such, with no dose upcharge and no introductory rate to step off
- Longer terms are published openly rather than used as a teaser — semaglutide falls to $189 on 12 weeks and $149 on 52
- A daily oral semaglutide tablet is offered alongside the injection
- Available in all 50 states and DC, with no minimum commitment and no cancellation fee
The caveats
- The flat rate is the highest entry price of the top-scoring programs here; the cheaper $149 figure needs a full year
- No FDA-approved brand-name pathway — the Wegovy and Ozempic pages are comparison content, not products
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
The verdict
Best for: Shoppers who want spanish-speaking patients wanting bilingual, LegitScript-certified compounded GLP-1. REMEVi is the first bilingual (English and Spanish) GLP-1 telehealth clinic — care delivered by clinicians trained in both languages, never auto-translated.
Ranked #34 of 539 providers we have reviewed — for comparison, read our ruling on CoreAge Rx, our #1 pick. In the ranking it sits between Live Vital at #33, 83/100 above and Rx.com at #35, 82/100 below, with the Synergy Rx ruling the next one down.
Weighing it against something else? Every provider we would put in front of REMEVi is ranked on price honesty, prescriber access and cancellation terms.If you would rather start from the top of the field, our full board of 539 providers is the place to start if you are still shortlisting. We have also ruled on it directly: CoreAge Rx vs REMEVi goes to CoreAge Rx, 94/100 to 83/100.
Compare with other providers
The closest rulings to REMEVi by Verdict Score — the realistic shortlist if you are weighing this one up.
- #27Hims & Hers— Mass-market, app-first weight program with nationwide reach and consumer-grade polish.85/100
- #28No BS RX— Six programs across four terms on one public page, four dispensing pharmacies named with addresses, and a no-intro-rate commitment the arithmetic actually supports.85/100
- #29Renlo Health— One of the few programs whose headline is the actual monthly rate, with the prescribing physician and the dispensing pharmacy both named.85/100
- #30Direct Meds— One of the rare programs offering an oral/sublingual route on both molecules with all-inclusive pricing — marked down hard because the numbers are company-stated rather than independently verified, and the company carries an FDA warning letter from September 2025.82/100
- #31Alan Meds— Rock-bottom pricing on both molecules plus an oral route, nationwide — with the trade-off of no LegitScript listing.84/100
- #32Henry Meds— A flat-fee compounded pioneer — simple model, but priced at the higher end now.84/100
Pricing, states and verification reflect REMEVi's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on REMEVi's site. Not medical advice; see our disclosure.